Evidence map›Paper›PMID 25582618›Full record

ArticleMolecular psychiatry2015

Psychiatric blood biomarkers: avoiding jumping to premature negative or positive conclusions.

A B Niculescu, D Levey, H Le-Niculescu, E Niculescu, S M Kurian, D Salomon

Abstract read
In one paragraph

Article in Molecular psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Genomewide association studies of suicide attempts in US soldiers.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2017
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

A B Niculescu1] Department of Psychiatry and Medical Neuroscience, Indiana University School of Medicine, Indianapolis, IN, USA [2] Indianapolis VA Medical Center, Indianapolis, IN, USA.
D Levey1] Department of Psychiatry and Medical Neuroscience, Indiana University School of Medicine, Indianapolis, IN, USA [2] Program in Medical Neuroscience, Paul and Carole Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.
H Le-NiculescuDepartment of Psychiatry and Medical Neuroscience, Indiana University School of Medicine, Indianapolis, IN, USA.
E NiculescuDepartment of Psychiatry and Medical Neuroscience, Indiana University School of Medicine, Indianapolis, IN, USA.
S M KurianDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA.
D SalomonDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA.

Funding

Developing Blood Tests for Mood DisordersDP2OD007363 · OD · INDIANA UNIVERSITY INDIANAPOLIS · PI NICULESCU, ALEXANDER B · 2010 to 2010
$2.3M
Mood State Blood Biomarkers: A Discovery-Based ApproachI01CX000139 · VA · RLR VA MEDICAL CENTER · PI NICULESCU, ALEXANDER B · 2009 to 2017
–
CSRD VA I01 CX000139NIH HHS DP2 OD007363
6 · The paper itself

Abstract

Blood biomarkers may provide a scientifically useful and clinically usable peripheral signal in psychiatry, as they have been doing for other fields of medicine. Jumping to premature conclusions, negative or positive, can create confusion in this field. Reproducibility is a hallmark of good science. We discuss some recent examples from this dynamic field, and show some new data in support of previously published biomarkers for suicidality (SAT1, MARCKS and SKA2). Methodological clarity and rigor in terms of biomarker discovery, validation and testing is needed. We propose a set of principles for what constitutes a good biomarker, similar in spirit to the Koch postulates used at the birth of the field of infectious diseases.

Indexed as

AcetyltransferasesBiomarkersBipolar DisorderChromosomal Proteins, Non-HistoneDiamine N-AcetyltransferaseFemaleHumansIntracellular Signaling Peptides and ProteinsMaleMembrane ProteinsMiddle AgedMyristoylated Alanine-Rich C Kinase SubstrateSuicideAcetyltransferasesBiomarkersChromosomal Proteins, Non-HistoneDiamine N-AcetyltransferaseIntracellular Signaling Peptides and ProteinsMARCKS protein, humanMembrane ProteinsMyristoylated Alanine-Rich C Kinase SubstrateSKA2 protein, human

Identifiers

PMID25582618
PMCPMC4357859

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.